News

Fort Washington, PA; 11 November, 2016 – FMD K&L Inc. (FMD K&L), a privately owned Contract Research Organization (CRO), is pleased to announce their new leadership team following a merger with iMEDGlobal Corporation (iMEDGlobal).  The new leadership team will work alongside the existing leadership to help define the strategy and company growth of its global operations.

Our newly promoted President of Global Biometrics, Tiepu Liu, recently held the Vice President of Biometrics role in the US at FMD K&L and has made numerous strides in the growth and success of the organization.  As part of his new role, he will oversee biostatistics, statistical programming, data management, project management, China’s biometrics, and Japan’s operations.

Our newly appointed President of Americas, Tim Seitter, will be responsible for managing...

Read more

Fort Washington, PA; 13 October, 2016 – FMD K&L Inc. (FMD K&L) and iMEDGlobal Corporation (iMEDGlobal) are pleased to announce that they have entered into a merger agreement. FMD K&L is a privately owned Contract Research Organization (CRO) with headquarters in the USA and China. iMEDGlobal is a privately owned CRO with headquarters in the USA and with main delivery centers in India and the Philippines. 

The services, clientele, and delivery centers of the companies are complementary in nature, providing  alignment towards the same strategic direction. The merger enables the combined entity to realize cost and revenue synergies across operational integration, a broader spectrum of services, an extended customer base, an expanded global presence, and a stronger sales...

Read more

12-May 2016: Fountain Medical Development (FMD), a full-service Contract Research Organization (CRO) headquartered in Beijing, China, and its US affiliate, FMD K&L, have adopted Oracle’s cloud-based clinical data management solutions, to increase operational efficiencies and speed time to market. The solutions deliver increased productivity to the company’s drug development process, reduce overall costs, improve communications with its sponsors, and advance clinical study quality and speed, worldwide. 

FMD was able to retire its aging, antiquated, legacy system and migrate to a more cost-effective cloud-based environment with Oracle Health Sciences InForm and Oracle Siebel Clinical Trial Management System (CTMS). The new, unified, technology platform has enhanced capabilities in data management, study planning and design, trial operations, analytics, and...

Read more

Pages